Thursday, May 8, 2025

Enhanced CAR T cell therapy offers new strategy for lymphoma

A phase I study of a next-generation CAR T cell therapy showed a 52 percent complete remission rate for patients with relapsed/refractory lymphoma.

from Latest Science News -- ScienceDaily https://ift.tt/pto7C5h
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Scientists discover what triggers belly fat as we age

Aging may trigger the appearance of specialized stem cells that supercharge the body's ability to create new belly fat. The discovery re...